Cerecor Inc. is a biopharmaceutical company that specializes in developing treatments for rare pediatric and orphan diseases. They are currently focused on developing a variety of therapies that range from anti-IL-18 monoclonal antibodies to oral prednisolone for the treatment of various conditions. Founded in 2011, Cerecor Inc. is headquartered in Rockville, Maryland.